Stenocare AS (OCSE:STENO) Shareholder Yield % : 5.00% (As of Mar. 2026)


OCSE:STENO Stenocare AS OCSE:STENO
50 GF Score
Price kr1.00
GF Value kr2.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Shareholder Yield %?

Stenocare AS OCSE:STENO +4.17% 50 Shareholder Yield % is 5.00% as of Mar. 2026. GuruFocus rates OCSE:STENO with a GF Score™ of 50/100 and a GF Value™ of kr2.31 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 972 Drug Manufacturers companies, Stenocare AS ranks better than 81.28% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Stenocare AS's Shareholder Yield % was 5.00%.


Stenocare AS  (OCSE:STENO) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Stenocare AS Shareholder Yield % Related Terms


Stenocare AS Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Stenocare AS's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Shareholder Yield % Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial 13.57 -6.75 -41.77 -6.70 -9.74

Stenocare AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.09 -15.72 -8.93 -9.74 4.90

OCSE:STENO vs ZTS, UTHR, VTRS: Shareholder Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stenocare AS Shareholder Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Stenocare AS's Shareholder Yield % falls into.


OCSE:STENO
50GF Score
Stenocare AS OCSE:STENO
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stenocare AS Shareholder Yield % Calculation

Stenocare AS's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+4.9 %
=4.9 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 5.00% mean?
Stenocare AS (OCSE:STENO) has a Shareholder Yield % of 5.00% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Stenocare AS and its competitors. According to the industry distribution chart, Stenocare AS ranks #182 out of 972 companies in the Drug Manufacturers industry, placing it in the top 18.7%.
Is Stenocare AS's Shareholder Yield % too high?
Stenocare AS's current Shareholder Yield % is 5.00%. The Drug Manufacturers industry median Shareholder Yield % is 0.30. Stenocare AS's value of 5.00% is 1566.7% above this industry median. Based on the distribution chart, Stenocare AS ranks #182 out of 972 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Stenocare AS has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Shareholder Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Stenocare AS ranks #182 out of 972 companies for Shareholder Yield %. This places Stenocare AS in the top 19% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.30. Stenocare AS's value of 5.00% is 1566.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.30, based on 972 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stenocare AS's current Shareholder Yield % of 5.00% is 1566.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Stenocare AS and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stenocare AS's current Shareholder Yield % is 5.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Based on GuruFocus' analysis, Stenocare AS (OCSE:STENO) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.31, compared to a current price of kr1.00 — trading 56.7% below its estimated fair value. The current Shareholder Yield % is 5.00% and 1566.7% above the Drug Manufacturers industry median of 0.30. Stenocare AS's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Stenocare AS (OCSE:STENO), the current Shareholder Yield % is 5.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stenocare AS (OCSE:STENO) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of kr1.00 is trading 56.7% below its estimated GF Value™ of kr2.31. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for OCSE:STENO:

  • Shareholder Yield %: 5.00%
  • GF Value™: kr2.31 vs. price of kr1.00 (56.7% below fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 1566.7% above the Drug Manufacturers median (#182 of 972)

No single metric tells the full story. See the OCSE:STENO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stenocare AS Business Description

Other Exchanges S7C:Germany
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
50GF Score

Get the complete analysis for OCSE:STENO

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.00
Price
kr2.31
GF Value